- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
Acetoxolone is a gastrointestinal drug used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, ulcerative colitis, and Crohn's disease. It is a prodrug of 5-aminosalicylic acid (5-ASA), which is the active ingredient in many anti-inflammatory drugs. Acetoxolone is available in both oral and rectal formulations, and is generally well tolerated with few side effects. It is often used in combination with other medications to treat more severe cases of gastrointestinal disorders.
Acetoxolone is a relatively new drug, and the market is still in its early stages. It is expected to grow in the coming years as more people are diagnosed with gastrointestinal disorders and as new formulations are developed. The drug is currently available in many countries, including the United States, Canada, and Europe.
Some companies in the Acetoxolone market include AbbVie, Allergan, AstraZeneca, and Pfizer. Show Less Read more